K. George

发表

CLASP: a randomised trial of low-dose aspirin for the prevention and treatment of pre-eclampsia among 9364 pregnant women

Jeffrey R. Wilson, R. Collins, G. Swingler, 1994, The Lancet.

Effi cacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission ( HPTN 046 ) : a randomised , double-blind , placebo-controlled trial

W. Fawzi, D. Moodley, L. Mofenson, 2011 .

Safety and Trough Concentrations of Nevirapine Prophylaxis Given Daily, Twice Weekly, or Weekly in Breast-Feeding Infants From Birth to 6 Months

D. Katzenstein, L. Mofenson, H. Coovadia, 2003, Journal of acquired immune deficiency syndromes.

Knowledge about vaccine trials and willingness to participate in an HIV/AIDS vaccine study in the Ugandan military.

E. Mugisha, J. McGrath, K. George, 2001 .

Fosamprenavir with Ritonavir Pharmacokinetics during Pregnancy

E. Capparelli, E. Joao, S. Burchett, 2020, Antimicrobial Agents and Chemotherapy.

Maternal and infant renal safety following tenofovir disoproxil fumarate exposure during pregnancy in a randomized control trial

B. Chi, D. Moodley, G. Theron, 2022, BMC Infectious Diseases.

Impact of Antiretroviral Therapy on Maternal Health after Cessation of Breastfeeding.

D. Moodley, G. Theron, J. Currier, 2020, Journal of acquired immune deficiency syndromes.

Impact of postpartum tenofovir-based antiretroviral therapy on bone mineral density in breastfeeding women with HIV enrolled in a randomized clinical trial

L. Mofenson, J. Shepherd, M. Fowler, 2021, PloS one.

The association between the ratio of monocytes: lymphocytes and risk of tuberculosis among HIV-infected postpartum women.

D. Moodley, H. McShane, H. Coovadia, 2014, Journal of acquired immune deficiency syndromes.

HIV Disease Progression in the First Year After Delivery Among African Women Followed in the HPTN 046 Clinical Trial

W. Fawzi, D. Moodley, H. Coovadia, 2013, Journal of acquired immune deficiency syndromes.

Pharmacokinetics and Safety of Tenofovir in HIV-Infected Women During Labor and Their Infants During the First Week of Life

L. Mofenson, M. Fowler, T. Taha, 2014, Journal of acquired immune deficiency syndromes.

Bone Age and Mineral Density Assessments Using Plain Roentgenograms in Tenofovir-exposed Infants in Malawi and Brazil Enrolled in HIV Prevention Trials Network 057

L. Mofenson, M. Boechat, J. Pinto, 2017, The Pediatric infectious disease journal.

Knowledge About Vaccine Trials and Willingness to Participate in an HIV/AIDS Vaccine Study in the Ugandan Military

E. Mugisha, J. McGrath, K. George, 2001, Journal of acquired immune deficiency syndromes.

Developing AIDS Vaccine Trials Educational Programs in Uganda

M. Kamya, M. Kamya, E. Mugisha, 2001, Journal of acquired immune deficiency syndromes.

Pharmacokinetics of tenofovir alafenamide with and without cobicistat in pregnant and postpartum women living with HIV: Results from IMPAACT P1026s.

R. Haubrich, E. Barr, E. Capparelli, 2020, AIDS.

Brief Report: Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/ HBV Coinfection

D. Moodley, J. Currier, M. Fowler, 2022, Journal of acquired immune deficiency syndromes.

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women

E. Capparelli, S. Burchett, T. Cressey, 2016, Journal of acquired immune deficiency syndromes.

Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV: Results From IMPAACT P1026s

E. Barr, E. Capparelli, M. Paul, 2022, Journal of acquired immune deficiency syndromes.

Impact of Maternal and Infant Antiretroviral Drug Regimens on Drug Resistance in HIV-infected Breastfeeding Infants

D. Moodley, L. Mofenson, H. Coovadia, 2013, The Pediatric infectious disease journal.

Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1-2 trial.

E. Acosta, J. Pinto, R. Hazra, 2022, The lancet. HIV.

Etravirine in treatment-experienced HIV-1-infected children 1 year to less than 6 years of age

H. Crauwels, B. Graham, L. Fairlie, 2021, AIDS.

Long-Term Safety and Efficacy of Dolutegravir in Treatment-Experienced Adolescents With Human Immunodeficiency Virus Infection: Results of the IMPAACT P1093 Study.

E. Acosta, R. Hazra, R. Viani, 2019, Journal of the Pediatric Infectious Diseases Society.

Effect on growth of exposure to maternal antiretroviral therapy in breastmilk versus extended infant nevirapine prophylaxis among HIV-exposed perinatally uninfected infants in the PROMISE randomized trial

M. Fowler, L. Stranix-Chibanda, G. Siberry, 2021, PloS one.

Brief Report: Impact of ART on Maternal Health After Cessation of Breastfeeding

D. Moodley, G. Theron, J. Currier, 2022, JAIDS Journal of Acquired Immune Deficiency Syndromes.

EXTENDED PROPHYLAXIS WITH NEVIRAPINE DOES NOT AFFECT GROWTH IN HIV-EXPOSED INFANTS.

W. Fawzi, H. Coovadia, M. Fowler, 2019, Journal of acquired immune deficiency syndromes.

Efficacy and safety of an extended nevirapine regimen in infant children of breastfeeding mothers with HIV-1 infection for prevention of postnatal HIV-1 transmission (HPTN 046): a randomised, double-blind, placebo-controlled trial

W. Fawzi, D. Moodley, L. Mofenson, 2012, The Lancet.

Efficacy and Safety of an Extended Nevirapine Regimen in Infants of Breastfeeding Mothers With HIV-1 Infection for Prevention of HIV-1 Transmission (HPTN 046): 18-Month Results of a Randomized, Double-Blind, Placebo-Controlled Trial

W. Fawzi, D. Moodley, L. Mofenson, 2014, Journal of acquired immune deficiency syndromes.

Bone and Renal Health in Infants With or Without Breastmilk Exposure to Tenofovir-Based Maternal Antiretroviral Treatment in the PROMISE Randomized Trial

D. Moodley, G. Theron, M. Fowler, 2023, Journal of acquired immune deficiency syndromes.

Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV

E. Capparelli, M. Paul, J. Momper, 2021, Journal of acquired immune deficiency syndromes.

Pharmacokinetics, safety, tolerability, and antiviral activity of dolutegravir dispersible tablets in infants and children with HIV-1 (IMPAACT P1093): results of an open-label, phase 1–2 trial

E. Acosta, J. Pinto, R. Hazra, 2022 .

Pharmacokinetics of Rilpivirine in HIV-Infected Pregnant Women

E. Capparelli, S. Burchett, T. Cressey, 2016, Journal of acquired immune deficiency syndromes.

Pharmacokinetics and safety of first-line tuberculosis drugs rifampin, isoniazid, ethambutol, and pyrazinamide during pregnancy and postpartum: results from IMPAACT P1026s

L. Wiesner, T. Cressey, M. Mirochnick, 2023, Antimicrobial agents and chemotherapy.